✦ LIBER ✦

Low-dose subcutaneous interleukin-2 in patients with minimal residual lymphoid neoplasm disease

✍ Scribed by Dr. E. González-Barca; A. Grañena; A. Fernández-Sevilla; V. Moreno; A. Salar; F. Rueda; J. García

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous low-dose recombinant interl

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

Post-transplant interleukin-2 in patient

✍ Jamie K. Waselenko; Ann Burrows; Douglas A. Nelson; Margaret Lucas; John Ekstran 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 151 KB

Biochemotherapy with low doses of subcut

✍ María González Cao; Susana Puig; Josep Malvehy; Josep Eugeni Herrero; Rosa María 📂 Article 📅 2005 🏛 Springer Milan 🌐 Spanish ⚖ 112 KB

A randomised study with subcutaneous low

✍ Lissoni, P; Barni, S; Tancini, G; Ardizzoia, A; Ricci, G; Aldeghi, R; Brivio, F; 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 728 KB

Phase IB study on prevention of surgery-

✍ Katia Cerea; Fabrizio Romano; Andrea Ferrari Bravo; Vittorio Motta; Fabio Uggeri 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Evaluation of natural killer cell expans

✍ N. J. Meropol; Grace M. Barresi; Todd A. Fehniger; James Hitt; Margaret Franklin 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 231 KB